Off-Balance sheet financing activities creat potential problems for financial statement users.
1. What is meant by off-balance sheet financing?
2. Do you think the pharmusotical company engages in off-balance sheet financing?What areas provide opportunity to do this?
3. Why would pharmusotical company want to engage in off-balance sheet financing?
4. What problems might off-balance sheet financing create for financial statement users?What would believers in market efficiency have to say about off-balance sheet financing activities?